Preventing Sexual Aggression Among High School Boys
|ClinicalTrials.gov Identifier: NCT02506088|
Recruitment Status : Active, not recruiting
First Posted : July 22, 2015
Last Update Posted : August 29, 2017
|Condition or disease||Intervention/treatment||Phase|
|Violence||Behavioral: Your Voice Your View||Not Applicable|
The present research advances the science of sexual assault prevention by creating a mutually beneficial partnership between well-established sexual assault prevention researchers and a CDC Rape Prevention and Education Program (RPE)-funded community agency to conduct a rigorous experimental evaluation of universal primary prevention programming designed to reduce sexual aggression among high school boys. The present research tests multi-session prevention programming that targets change at multiple levels of the social ecology (i.e., individual-, peer- and community-level) through social norms theory and bystander education. Specifically, the present research evaluates Your Voice Your View. Your Voice Your View was developed and is currently administered in Rhode Island High Schools by the CDC RPE-funded agency Day One of Rhode Island. The program will be tested in a group randomized cluster trial among 10th graders at 30 high schools, with the aim of reducing perpetration of sexual aggression among high school boys.
Specifically, this research will conduct a randomized controlled trial with a sample of 10th grade students to demonstrate efficacy of the intervention in reducing rates of sexual aggression among high school boys, rates of dating violence involvement, and related risk and protective factors over a 2- and 6-month follow-up in comparison to a wait-list control group. Thirty schools will be matched on demographic characteristics (i.e., % receiving subsidized lunch, racial/ethnic minority enrollment) and randomized to receive Your Voice Your View or to the wait-list control group.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||9000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Preventing Sexual Aggression Among High School Boys|
|Study Start Date :||September 2015|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 2018|
Experimental: Your Voice Your View
Participants in schools assigned to the treatment group will engage in a four session intervention aimed at prevention of sexual violence. Your Voice Your View is grounded in social norms theory and bystander intervention training. The intervention also includes a social norms marketing campaign.
Behavioral: Your Voice Your View
Session 1 of the intervention involves background information, an introduction to social norms, and bystander intervention skills training. Session 2 of the intervention establishes conditions for consent, types of abusive behavior and identifying abuse. Session 3 of the intervention addresses risk reduction strategies for girls. Session 3 of the intervention addresses false accusations, masculinity, and additional practice on identifying conditions for consent for boys. Session 4 of the intervention includes active practice of bystander intervention skills.
No Intervention: Wait List Control Group
Participants in schools assigned to the wait list control group will complete survey assessments at the same schedule as schools assigned to the treatment group. Schools will have the option to implement Your Voice Your View following completion of the 6-month survey.
- Perpetration of Sexual Violence Survey [ Time Frame: up to 6-months ]
- Rate of Dating Violence Perpetration [ Time Frame: up to 6 months ]
- Rape Myth Acceptance Survey [ Time Frame: up to 6 months ]
- Bystander Intervention Skills Survey [ Time Frame: up to 6 months ]Composite measure: Increase Positive Bystander Behavior, Decrease Barriers to Intervening, Increase Likelihood of Intervening
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02506088
|United States, Rhode Island|
|Rhode Island Hospital|
|Providence, Rhode Island, United States, 02904|
|Principal Investigator:||Lindsay M. Orchowski, Ph.D.||Rhode Island Hospital|